Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 126 entries
View as:
Phase: N/A
Priority: Normal
Start: 05/31/06
End: 04/30/09
Due: 04/30/10
Phase: N/A
Priority: Normal
Start: 10/31/07
End: 10/31/12
Due: 10/31/13
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 04/19/18
Due: 04/19/19
Phase: N/A
Priority: Normal
Start: 08/31/12
End: 10/31/13
Due: 10/31/14
Phase: N/A
Priority: Normal
Start: 01/31/09
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 01/07/22
End: 12/11/23
Due: 12/11/24
Phase: N/A
Priority: Normal
Start: 05/29/24
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 01/07/16
End: 04/15/21
Due: 04/15/22
Phase: N/A
Priority: Normal
Start: 02/26/15
End: 02/09/24
Due: 02/09/25
Phase: N/A
Priority: Normal
Start: 10/31/16
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 12/31/14
Due: 12/31/15
Phase: N/A
Priority: Normal
Start: 03/23/18
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 01/31/17
Due: 01/31/18
Phase: N/A
Priority: Normal
Start: 08/30/11
End: 03/01/19
Due: 03/01/20
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 09/30/19
Due: 09/30/20
Phase: N/A
Priority: Normal
Start: 09/30/18
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 01/31/07
End: 07/31/09
Due: 07/31/10
Phase: N/A
Priority: Normal
Start: 03/11/20
End: 12/31/23
Due: 12/31/24
Phase: N/A
Priority: Normal
Start: 10/31/07
End: -
Due: -
Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 01/31/08
Due: 01/31/09
Phase: N/A
Priority: Normal
Start: 01/19/24
End: 10/08/24
Due: 10/08/25
Phase: N/A
Priority: Normal
Start: 10/31/11
End: 03/31/19
Due: 03/31/20
Phase: N/A
Priority: Normal
Start: 06/30/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/25/16
End: 01/31/21
Due: 01/31/22
Phase: N/A
Priority: Normal
Start: 09/14/22
End: 10/31/28
Due: 10/31/29